Search Within

Alice Zervoudakis

Formats
  1. Meeting Abstract (18)
  2. Journal Article (15)
Groups
  1. Department of Medicine (33)
  2. Gastrointestinal Oncology Service (33)
  3. Solid Tumor Oncology Division (33)
  4. Center for Pancreatic Cancer Research (30)
  5. Survivorship Research (17)
  6. Biostatistics Service (16)

More Groups

People
  1. Eileen O'Reilly (15)
  2. Kenneth Yu (12)
  3. Diane Reidy (11)
  4. Joanne Chou (11)
  5. Robert Daly (11)
  6. Brett Simon (10)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. JAMA Network Open (2)
  3. JCO Oncology Practice (2)
  4. American Society of Clinical Oncology Educational Book (1)
  5. Annals of Oncology (1)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Medical Association (2)
  3. Karger (2)
  4. American Association for Cancer Research (1)
  5. American Society of Hematology (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors
    Meeting Abstract

    Chung, V.; Kochenderfer, M. D.; Natarajan, N.; Williams, G. R.; Laursen, A. A.; Cockrum, P.; Rhodes, W.; Surinach, A.; Zhang, L.; Li, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Impact of UGT1A1*28 polymorphism on tolerability in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with NALIRIFOX in NAPOLI 3
    Meeting Abstract

    Abdelrahim, M.; Khan, G.; Hatoum, H.; Zervoudakis, A.; Dayyani, F.; Zhang, L.; Li, J.; Maxwell, F.; O'Reilly, E. M.; Wainberg, Z. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication
    Journal Article

    Singh, I.; Chou, J. F.; Capanu, M.; Park, J.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Keane, F.; Rolston, V. S.; more...
    Pancreatology (2024)

    Fulltext@MSK | Save
  • Association of sex and obesity on overall survival in patients undergoing upfront surgery for resectable pancreatic adenocarcinoma
    Meeting Abstract

    Judge, S. J.; Manin, E.; Chou, J.; Kingham, T. P.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J.; Park, W.; Zervoudakis, A.; Varghese, A.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical importance of clonal hematopoiesis in metastatic gastrointestinal tract cancers
    Journal Article

    Diplas, B. H.; Ptashkin, R.; Chou, J. F.; Sabwa, S.; Foote, M. B.; Rousseau, B.; ArgileĢs, G.; White, J. R.; Stewart, C. M.; Bolton, K.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC)
    Meeting Abstract

    Keane, F.; Schoenfeld, J. D.; Crowley, F.; O'Connor, C. A.; White, C.; Schwartz, C.; Brenner, R.; Larsen, M.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy
    Journal Article

    Daly, B.; Nicholas, K. J.; Flynn, J.; Panageas, K. S.; Silva, N.; Duck, E.; Zervoudakis, A.; Holland, J.; Salvaggio, R.; Begue, A.; more...
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save